Abiopharma

🔍 Olivera Matias (Executive)

Company: Exodus Movement, Inc. (EXOD)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 2,835 shares of Class A Common Stock at $7.81 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 331,593.00 | transaction_form_type: 4
• Sold 2,835 shares of Class A Common Stock at $7.68 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 328,758.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Includes (i) 2,171 Restricted Stock Units ("RSU") originally granted on January 1, 2023 that vest in equal monthly installments through January 1, 2027 and (ii) 18,615 RSUs originally granted on July 1, 2023 that vest in equal monthly installments through July 1, 2027 and (iii) 36,214 RSUs originally granted on March 13, 2024 that vest in equal monthly installments through January 1, 2028 and (iv) 25,818 RSUs originally granted on May 21, 2025 that vest in equal monthly installments through January 1, 2029 and (v) 41,667 RSUs originally granted on December 30, 2025 that vest in equal monthly installments through December 1, 2029. Each RSU represents the right to receive one share of Common Stock upon settlement.